Business
REG - Novacyt S.A. - Notice of AGM
REG - Novacyt S.A. - Notice of AGM
About this update from Novacyt Sas
RNS Number : 1407I Novacyt S.A. 12 May 2025 Novacyt S.A.("Novacyt", the "Company" or the "Group")Notice of AGMParis, France, and Manchester, UK - 12 May 2025 - Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces that its Annual General Meeting ("AGM") will be held in person at 1pm CEST/12pm BST on Thursday, 19 June 2025 at the Hilton Hotel, Paris Charles de Gaulle Airport, France.A video recording of the AGM will be available to view on the Company website shortly after the conclusion of the meeting.ContactsNovacyt SAhttps://novacyt.com/investorsLyn Rees, Chief Executive Officer Via Walbrook PRSteve Gibson, Chief Financial Officer SP Angel Corporate Finance LLP (Nominated Adviser and Broker)+44 (0)20 3470 0470Matthew Johnson / Charlie Bouverat (Corporate Finance)Vadim Alexandre / Rob Rees (Corporate Broking)Deutsche Numis (Joint Broker)+44 (0)20 7260 1000Freddie Barnfield / Duncan Monteith / Michael PalserAllegra Finance (French Listing Sponsor)Rémi Durgetto / Yannick Petit +33 (1) 42 22 10 10 [email protected] / [email protected] PR (Financial PR & IR)Paul McManus / Lianne ApplegarthAlice Woodings+44 (0)20 7933 8780 or [email protected]+44 (0)7980 541 893 / +44 (0)7584 391 303 +44 (0)7407 804 654About Novacyt Group (www.novacyt.com)Novacyt is an international molecular diagnostics company providing a broad portfolio of integrated technologies and services, primarily focused on the delivery of genomic medicine. The Company develops, manufactures, and commercialises a range of molecular assays and instrumentation to deliver workflows and services that enable seamless end-to-end solutions from sample to result across multiple sectors including human health, animal health and environmental.The Company is divided into three business segments:ClinicalBroad portfolio of human clinical in vitro diagnostic products, workflows and services focused on three therapeutic areas:· Reproductive Health: NIPT, Cystic Fibrosis and other rapid aneuploidy tests· Precision Medicine: DPYD genotyping assay· Infectious Diseases: Winterplex, multiplex winter respiratory PCR panelInstrumentationPortfolio of next generation size selection DNA sample preparation platforms and rapid PCR machines, including:· Ranger® Technology: autom...